EnPlusOne Biosciences
EnPlusOne Biosciences is a biotechnology company developing the ezRNA™ synthesis platform. This platform utilizes enzymes to deliver better RNA at scale, enabling the creation of next-generation solutions for emerging RNA therapeutics. Their enzymatic, water-based approach aims to unlock sustainable and scalable commercial manufacturing of RNA therapeutics.
Funding Round:
Funding Amount: $10M
Date: 19-Feb-2025
Investors: Northpond Ventures, Breakout Ventures
Markets: Biotechnology, RNA Therapeutics
HQ: Watertown, Massachusetts, United States
Founded: 2022
Website: https://www.enplusonebio.com/
LinkedIn: https://www.linkedin.com/company/enplusone-bio
Twitter: https://twitter.com/enplusone_bio
Crunchbase: https://www.crunchbase.com/organization/enplusone-biosciences
Leave a Comment
Comments
No comments yet.